According to the General Administration of Market Regulation, recently, an amino acid component formula for special medical use suitable for patients with phenylketonuria aged 1 year and above was approved for registration, making it the first formula for special medical use with nutrient components suitable for patients with rare diseases in China.

According to the General Administration of Market Regulation, recently, an amino acid component formula for special medical use suitable for patients with phenylketonuria aged 1 year and above was approved for registration, making it the first formula for special medical use with nutrient components suitable for patients with rare diseases in China.